Pilulka Lékárny a.s. (PRA:PINK)

Pilulka Lékárny a.s. Income Statement

Financials in millions CZK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	2,132	2,447	2,380
Revenue Growth (YoY)	-12.89%	2.81%	-
Cost of Revenue	1,835	2,047	2,367
Gross Profit	297.34	400.7	13.52
Selling, General & Admin	364.46	400.43	-
Other Operating Expenses	7.51	-2.67	15.4
Operating Expenses	445.91	448.47	27.51
Operating Income	-148.57	-47.77	-13.99
Interest Expense	-10.48	-4.76	-0.78
Interest & Investment Income	0.05	0.21	0.71
Other Non Operating Income (Expenses)	-16.88	-11.78	-10.63
EBT Excluding Unusual Items	-175.89	-64.11	-24.68
Gain (Loss) on Sale of Assets	0.02	0.1	-
Pretax Income	-175.87	-64.01	-24.68
Income Tax Expense	0	1.75	0.99
Earnings From Continuing Operations	-175.88	-65.76	-25.67
Minority Interest in Earnings	0.93	0.82	0.18
Net Income	-174.94	-64.94	-25.5
Net Income to Common	-174.94	-64.94	-25.5
Shares Outstanding (Basic)	3	3	-
Shares Outstanding (Diluted)	3	3	-
Shares Change (YoY)	7.36%	-	-
EPS (Basic)	-64.63	-25.76	-
EPS (Diluted)	-64.63	-25.76	-
Free Cash Flow	-69.92	-114.92	-57.46
Free Cash Flow Per Share	-25.83	-45.59	-
Gross Margin	13.95%	16.37%	0.57%
Operating Margin	-6.97%	-1.95%	-0.59%
Profit Margin	-8.21%	-2.65%	-1.07%
Free Cash Flow Margin	-3.28%	-4.70%	-2.41%
EBITDA	-125.75	-29.92	8.33
EBITDA Margin	-5.90%	-1.22%	0.35%
D&A For EBITDA	22.83	17.85	22.31
EBIT	-148.57	-47.77	-13.99
EBIT Margin	-6.97%	-1.95%	-0.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.